|Bid||105.62 x 800|
|Ask||105.96 x 1200|
|Day's Range||100.42 - 106.50|
|52 Week Range||41.66 - 286.19|
|Beta (5Y Monthly)||1.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 23, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||114.80|
Subscribe to Yahoo Finance Plus to view Fair Value for IRTCLearn more
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 25.69% and 2.27%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
SAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended September 30, 2021. Third Quarter 2021 Financial Highlights Revenue was $85.4 million, a 18.7% increase compared to third quarter 2020Gross margin was 65.7%, a 8.9% decrease compared to third quarter 2020Adjusted EBITDA (defined as EBITDA less stock compen
Shares of iRhythm Technologies (NASDAQ: IRTC) skyrocketed by 59% in Wednesday trading after the Centers for Medicare and Medicaid Services (CMS) released its Calendar Year 2022 Medicare Physician Fee Schedule (MPFS) Final Rule on Tuesday. The MPFS details the payment policies and rates for services provided to Medicare beneficiaries.